Mollison’s Blood Transfusion in Clinical Medicine - part 1 pps

... edition 19 67 Eighth edition 19 87Reprinted 19 67 Reprinted 19 88Library of Congress Cataloging -in- Publication DataKlein, Harvey G. Mollison’s blood transfusion in clinical medicine. – 11 th ed. ... Loudon). Blood transfusion in clinical medicine. IV. Title.V. Title: Blood transfusion in clinical medicine. [DNLM: 1. Blood Transfusion. WB 356 K64m 2005]RM1 71. M6 2005 615 ′.39–dc222005 012 644A ... Mollison’s Blood Transfusion in Clinical Medicine 11 TH EDITIONHarvey G. Klein MDPresident of the American Association of Blood Banks;Chief, Department of Transfusion Medicine Warren...

... 50–55Springer GF, Horton RE (19 69) Blood group isoantibodystimulation in man by feeding blood group-active bacteria.J Clin Invest 48: 12 80Springer GF, Tegtmeyer H (19 81) Origin of anti-Thomsen-Friedenreich ... PressHughes-Jones NC, Gardner B (19 62) The exchange of 13 1I-labelled lipid and 13 1I-labelled protein between red cells andserum. Biochem J 83: 404Hughes-Jones NC, Ghosh S (19 81) Anti-D-coated Rh-positivered ... cells in serumO – None*Anti-AAnti-A 1 Anti-BAnti-A,B†AA 1 A + A 1 A2AAnti-B‡B– BAnti-AAnti-A 1 AB A 1 BA +A 1 + BNil‡A2BA +B* With very rare exceptions human red cells contain...

... com-prises 732 amino acids. It is a type II membrane pro-tein with its amino-terminal domain in the cytosol, a single membrane-spanning domain and a largeextracellular carboxy-terminal domain ... 473–477Spring FA, Parsons SF, Ortlepp S et al. (20 01) Intercellularadhesion molecule-4 binds alpha(4)beta (1) and alpha(V )- family integrins through novel integrin-binding mechan-isms. Blood 98: ... voies intra-musculaire et intra-veineuse. Rev Fr Transfus 13 : 2 31 Huestis DW (19 71) In: International Forum: What consti-tutes adequate routine Rh typing on donors and recipients?Vox Sang 21: 18 3Hughes-Jones...

... of agglutination tests is increased in various ways, 0 10 2030405060708090 10 0TubeCATMP-LPMP-SPMultiple 19 90 19 92 19 96 19 97 19 98 19 99Fig 8 .1 Trends in indirectantiglobulin test ... cold hemag-glutinins. Vox Sang 55: 21 25Salama A, Berghöfer H, Mueller-Eckhardt C (19 92) Red blood cell transfusion in warm-type autoimmune haemolyticanaemia. Lancet 340: 15 15 15 17Sangster ... et al. 19 68b). IgA alone was found in 3 out of 2 91 cases in one series (Worlledge 19 78), in 2 out of 10 2 cases in another series (Petz and Garratty 19 80), and in 11 out of 13 74 patients in a...

... Rood 19 61; Finke et al. 19 65; Garby andMollison 19 71) . As expected, though, the 51 Cr methodis insensitive in detecting slight increases in red celldestruction (Cline and Berlin 19 63b; Finke ... (19 89c) In vivo regenerationof red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS -1 , AS-3 and CPDA -1 red cells. Transfusion 71: 13 1 13 6Heaton WAL, Keegan T, Holme S (19 89d) ... A et al. (19 91) Storage ofsaline-adenine-glucose-mannitol-suspended red cells in anew plastic container: polyvinylchloride plasticized withbutyryl-n-trihexyl-citrate. Transfusion 31: 26–29Högman...

... -E, 12 ; -C or -Cw, 3; -C, -E, 1; -e, 1; Jk system: 27 (-Jka,24; -Jkb, 23); Fy system: 13 (all -Fya); Kell system: 12 (all anti-K); MNSs system: 4 (-M, 2; -S, 1; -s, 1) ;anti-A 1 , 1; ... 529–559Mollison PL (19 51) Blood Transfusion in Clinical Medicine, 1st edn. Oxford: Blackwell Scientific PublicationsMollison PL (19 67) Blood Transfusion in Clinical Medicine, 4th edn. Oxford: ... (Boorman et al. 19 46; Salmon et al. 19 59; Perkins et al. 19 64;Lundberg and McGinniss 19 75; Pineda et al. 19 78a);anti-P 1 in one (Dinapoli et al. 19 77); and anti-M in one(Alperin et al. 19 83).Lewis...

... COMPONENTS575CHAPTER 13 548 0- 10 0- 20 0- 30 0- 40 0- 50 0- 60 0- 70 0- 80 0- 90 0- 10 0 0- 11 0 0- 12 0 0- 13 0 0- 14 0 0- 15 0 0- 16 0 0- 17 0 0- 18 0 0- 19 0 0- 200 0- 210 0- 220 0- 230 0- 240 0- 250 0- 260 0- 270 0- 280 0- 290 0- 300 0- 310 0- 320 0- 330 0- 340 0- HFECLASSICLASSIIICLASSIIHLA-FMICEMICDMICC6p 21. 31 HLA-DRB9HLA-DRB2HLA-DQB3HLA-DQA2HLA-DQB2HLA-DPA2HLA-DPA3HLA-DPB2HLA-HHLA-GHLA-AHLA-EHLA-CHLA-BMICATNFAHSPA1LHLA-DOBTAP2LMP7TAP1LMP2HLA-DMBHLA-DMAHLA-DOAHSPA1AHSPA1BC2C4BP450-C21BHLA-DRAHLA-DRB3HLA-DRB1HLA-DQA1HLA-DQB1HLA-DPA1HLA-DPB1BFMICBTNFBFig ... 13 548 0- 10 0- 20 0- 30 0- 40 0- 50 0- 60 0- 70 0- 80 0- 90 0- 10 0 0- 11 0 0- 12 0 0- 13 0 0- 14 0 0- 15 0 0- 16 0 0- 17 0 0- 18 0 0- 19 0 0- 200 0- 210 0- 220 0- 230 0- 240 0- 250 0- 260 0- 270 0- 280 0- 290 0- 300 0- 310 0- 320 0- 330 0- 340 0- HFECLASSICLASSIIICLASSIIHLA-FMICEMICDMICC6p 21. 31 HLA-DRB9HLA-DRB2HLA-DQB3HLA-DQA2HLA-DQB2HLA-DPA2HLA-DPA3HLA-DPB2HLA-HHLA-GHLA-AHLA-EHLA-CHLA-BMICATNFAHSPA1LHLA-DOBTAP2LMP7TAP1LMP2HLA-DMBHLA-DMAHLA-DOAHSPA1AHSPA1BC2C4BP450-C21BHLA-DRAHLA-DRB3HLA-DRB1HLA-DQA1HLA-DQB1HLA-DPA1HLA-DPB1BFMICBTNFBFig 13 .1 The ... 13 548 0- 10 0- 20 0- 30 0- 40 0- 50 0- 60 0- 70 0- 80 0- 90 0- 10 0 0- 11 0 0- 12 0 0- 13 0 0- 14 0 0- 15 0 0- 16 0 0- 17 0 0- 18 0 0- 19 0 0- 200 0- 210 0- 220 0- 230 0- 240 0- 250 0- 260 0- 270 0- 280 0- 290 0- 300 0- 310 0- 320 0- 330 0- 340 0- HFECLASSICLASSIIICLASSIIHLA-FMICEMICDMICC6p 21. 31 HLA-DRB9HLA-DRB2HLA-DQB3HLA-DQA2HLA-DQB2HLA-DPA2HLA-DPA3HLA-DPB2HLA-HHLA-GHLA-AHLA-EHLA-CHLA-BMICATNFAHSPA1LHLA-DOBTAP2LMP7TAP1LMP2HLA-DMBHLA-DMAHLA-DOAHSPA1AHSPA1BC2C4BP450-C21BHLA-DRAHLA-DRB3HLA-DRB1HLA-DQA1HLA-DQB1HLA-DPA1HLA-DPB1BFMICBTNFBFig...

... In a Joint Euro-pean Study comprising 10 4 cases, anti-HPA-1a wasfound in 88, anti-HPA-1b in five, anti-HPA-3a in six and anti-HPA-3b in one case (Mueller-Eckhardt 19 91) . Antibodies against an ... specific inhibitor of thrombin. J Lab ClinMed 11 1: 11 8 12 4Bode AP, Miller DT (19 89) The use of thrombin inhibitorsand aprotinin in the preservation of platelets stored for transfusion. J Lab Clin ... Arch Intern Med 16 1: 714 – 718 Bork K, Witzke G (19 89) Long-term prophylaxis with C 1- inhibitor (C1 INH) concentrate in patients with recurrentangioedema caused by hereditary and acquired C 1- inhibitor...

... 227–234Minamoto GY, Scheinberg DA, Dietz K et al. (19 88) Humanimmunodeficiency virus infection in patients withleukemia. Blood 71: 11 47 11 49Mintz ED, Anderson JF, Cable RG (19 91) Transfusion- transmitted ... use in testing ofwhole -blood- derived leukoreduced platelet-rich-plasma-derived platelets. Transfusion 44: 11 74 11 78Brennan MT, Runganga J, Barbara JAJ et al. (19 92). Theprevalence of anti-HTLV ... Transfusion 28: 18 7 18 9Jacobs J, Jamaer D, Vandeven J et al. (19 89) Yersinia entero-colitica in donor blood: a case report and review. J ClinMicrobiol 27: 11 19 11 21 Jacoby GA, Hunt JV, Kosinski KS...

... platelets for labelling with 11 1indium oxineUsing a 19 -G needle, collect 51 ml of venous blood into a 60-ml sterile plastic syringe containing 9 ml of ACD-A. A clean ‘non-traumatic’ venepuncture ... 0.8 ml of theremaining labelled solution from the tube containingthe 51 Cr- and 11 1 In- labelled platelets into a 1- cc syringethrough a 16 -G needle to be used for standard pre-paration. Record ... before initiating radiolabelling.Platelet labelling with 11 1indium oxineAdd 50–60 µCi of 11 1indium oxine labelling solution tothe washed platelet suspension. Incubate at 20–24°C for20 min...